ÐÜèÊÓƵ

Skip to Content
Resources

ÐÜèÊÓƵComment Letter to FTC on Competition in Prescription Drug Markets

Comment Letter

Document Info

Published on Dec 8, 2017

Download and read the full Resource.

Related Issues
High-Price Drugs

Resource Details

On December 8, ÐÜèÊÓƵsubmitted comments to the Federal Trade Commission (FTC) for the official record of an FTC workshop held in early November on ways to promote greater competition in prescription drug markets—as a way to both reduce costs and improve access to drugs and treatments.